Yoko Bian

FDA Approves Celltrion's New Pediatric Formulation Of STEQEYMA, Expanding Dosing Flexibility

Alvotech And Teva Announce Acceptance Of BLA For AVT05, A Golimumab Biosimilar

Recent Ustekinumab And Denosumab Biosimilars Deals

FDA Designates Intellia's Nexiguran Ziclumeran (Nex-z) As A Regenerative Medicine Advanced Therapy

Update On Recent International Biosimilar Approvals

FDA Issues Draft Guidance On Demonstrating Biosimilar Interchangeability

MDL Panel Grants Transfer Of Aflibercept BPCIA Case